50 results
424B5
MIRM
Mirum Pharmaceuticals Inc
2 Nov 23
Prospectus supplement for primary offering
4:59pm
materially from those projected in the forward-looking statements. Moreover, we operate in an evolving environment. New risk factors and uncertainties may … in an evolving environment. New risk factors and uncertainties may emerge from time to time, and it is not possible for our management to predict all risk
S-3ASR
xq7u0s
13 Oct 23
Automatic shelf registration
4:47pm
8-K
EX-99.1
ayb9u4hzymdgr
13 Oct 23
Other Events
4:16pm
8-K
EX-2.1
jb899lvat3086lq2
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
S-3ASR
sx8hhjtdr46cxg
9 Sep 22
Automatic shelf registration
4:31pm
424B5
oisnh fj73
10 Aug 22
Prospectus supplement for primary offering
5:07pm
8-K
EX-1.1
ldua6p qihld1ymw0cmm
10 Aug 22
Other Events
12:00am
424B5
8i1hhtqqvlt2u
9 Aug 22
Prospectus supplement for primary offering
12:00am